Advertisement
Advertisement
U.S. markets open in 1 hour 48 minutes
Advertisement
Advertisement
Advertisement
Advertisement

ChemoCentryx, Inc. (CCXI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
34.85+1.20 (+3.57%)
At close: 4:00PM EDT
34.87 +0.02 (+0.06%)
Pre-Market: 07:42AM EDT
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
21,176
64,392
35,952
42,875
82,497
Operating Expense
142,681
119,569
94,255
83,145
66,004
Operating Income
-121,505
-55,177
-58,303
-40,270
16,493
Net Non Operating Interest Income Expense
-1,351
-179
2,814
2,304
1,366
Other Income Expense
-
-179
2,814
2,304
1,366
Pretax Income
-122,856
-55,356
-55,489
-37,966
17,859
Net Income Common Stockholders
-122,856
-55,356
-55,489
-37,966
17,859
Diluted NI Available to Com Stockholders
-122,856
-55,356
-55,489
-37,966
17,859
Basic EPS
-
-0.84
-0.98
-0.76
0.37
Diluted EPS
-
-0.84
-0.98
-0.76
0.36
Basic Average Shares
-
65,688
56,898
49,814
48,413
Diluted Average Shares
-
65,688
56,898
49,814
49,615
Total Operating Income as Reported
-121,505
-55,177
-58,303
-40,270
16,493
Total Expenses
142,681
119,569
94,255
83,145
66,004
Net Income from Continuing & Discontinued Operation
-122,856
-55,356
-55,489
-37,966
17,859
Normalized Income
-122,856
-55,356
-55,489
-37,966
17,859
Interest Income
1,433
2,464
4,963
3,528
1,370
Interest Expense
2,784
2,643
2,149
1,224
4
Net Interest Income
-1,351
-179
2,814
2,304
1,366
EBIT
-120,072
-52,713
-53,340
-36,742
17,863
EBITDA
-118,430
-
-
-
-
Reconciled Depreciation
1,642
797
1,642
512
418
Net Income from Continuing Operation Net Minority Interest
-122,856
-55,356
-55,489
-37,966
17,859
Normalized EBITDA
-118,430
-51,916
-51,698
-36,230
18,281
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement